Skip to Content

WATSON 461 (Glipizide 10 mg)

Pill with imprint WATSON 461 is White, Round and has been identified as Glipizide 10 mg. It is supplied by Watson Laboratories, Inc..

Glipizide is used in the treatment of diabetes, type 2 and belongs to the drug class sulfonylureas. Risk cannot be ruled out during pregnancy. Glipizide 10 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for WATSON 461

Glipizide 10 mg WATSON 461
Glipizide 10 mg WATSON 461
Glipizide 10 mg WATSON 461 Front
Glipizide 10 mg WATSON 461 Back
Glipizide 10 mg WATSON 461
Glipizide 10 mg WATSON 461

Glipizide

Imprint
WATSON 461
Strength
10 mg
Color
White
Size
10.00 mm
Shape
Round
Availability
Prescription only
Drug Class
Sulfonylureas
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Watson Laboratories, Inc.
Inactive Ingredients
silicon dioxide, croscarmellose sodium, lactose anhydrous, microcrystalline cellulose, corn starch, stearic acid

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code Labeler / Repackager
00591-0461 Watson Pharmaceuticals, Inc.
54569-3842 A-S Medication Solutions, LLC (repackager)
54868-3319 Physicians Total Care Inc. (repackager)
63874-0432 Altura Pharmaceuticals Inc. (repackager)
67544-0129 Prepak Systems Inc. (repackager)

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.